๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)

โœ Scribed by Yin-Mei Lee; Dede S. Sutedja; Chun-Tao Wai; Yock-Young Dan; Myat-Oo Aung; Lei Zhou; Chee-Leong Cheng; Aileen Wee; Seng-Gee Lim

Book ID
107593757
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
210 KB
Volume
2
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Metformin in the treatment of patients w
Metformin in the treatment of patients with non-alcoholic steatohepatitis
โœ A. Uygun; A. Kadayifci; A. T. Isik; T. Ozgurtas; S. Deveci; A. Tuzun; Z. Yesilov ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB

## Summary **Background** :โ€‚Increased insulin resistance is the major pathogenic mechanism in the development of nonโ€alcoholic steatohepatitis. **Aim** :โ€‚To investigate the therapeutic effect of metformin, a wellโ€known insulinโ€sensitizing agent, in the treatment of nonโ€alcoholic steatohepatitis.

Ursodeoxycholic acid or clofibrate in th
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study
โœ J Laurin; K D Lindor; J S Crippin; A Gossard; G J Gores; J Ludwig; J Rakela; D B ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB ๐Ÿ‘ 1 views

Non-alcohol-induced steatohepatitis (NASH) is characterized by elevated serum aminotransferase activities with hepatic steatosis, inflammation, and occasionally fibrosis that may progress to cirrhosis. No established treatment exists for this potentially serious disorder. Our aim was to conduct a pi